X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (151) 151
Publication (23) 23
Book / eBook (11) 11
Book Review (3) 3
Patent (2) 2
Book Chapter (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (70) 70
index medicus (55) 55
female (50) 50
male (49) 49
middle aged (46) 46
aged (44) 44
cardiac & cardiovascular systems (41) 41
abridged index medicus (35) 35
myocardial infarction (30) 30
acute coronary syndromes (28) 28
risk factors (27) 27
treatment outcome (27) 27
heart attacks (26) 26
mortality (23) 23
double-blind method (21) 21
cardiovascular diseases (19) 19
risk (19) 19
drug therapy (18) 18
ischemia (18) 18
coronary heart disease (17) 17
myocardial infarction - drug therapy (17) 17
aspirin (16) 16
clopidogrel (16) 16
kaplan-meier estimate (16) 16
myocardial infarction - mortality (16) 16
stroke (16) 16
medicine, general & internal (15) 15
secondary prevention (15) 15
cardiovascular (14) 14
prevention (14) 14
cardiovascular disease (13) 13
diabetes (13) 13
dosage and administration (13) 13
hemorrhage - chemically induced (13) 13
acute coronary syndrome (12) 12
care and treatment (12) 12
follow-up studies (12) 12
management (12) 12
myocardial-infarction (12) 12
patients (12) 12
acute coronary syndrome - drug therapy (11) 11
analysis (11) 11
metaanalysis (11) 11
cardiology (10) 10
cardiovascular diseases - prevention & control (10) 10
cerebral infarction (10) 10
heart attack (10) 10
life sciences (10) 10
percutaneous coronary intervention (10) 10
peripheral vascular disease (10) 10
platelet aggregation inhibitors - administration & dosage (10) 10
prospective studies (10) 10
stroke - prevention & control (10) 10
antiplatelet therapy (9) 9
cardiovascular diseases - mortality (9) 9
drug therapy, combination (9) 9
internal medicine (9) 9
outcomes (9) 9
percutaneous coronary intervention - methods (9) 9
platelet aggregation inhibitors - adverse effects (9) 9
platelet aggregation inhibitors - therapeutic use (9) 9
ticagrelor (9) 9
time factors (9) 9
coronary vessels (8) 8
death (8) 8
diabetes mellitus (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
myocardial infarction - diagnosis (8) 8
myocardial infarction - epidemiology (8) 8
original research (8) 8
patient outcomes (8) 8
ticlopidine - analogs & derivatives (8) 8
adult (7) 7
artery-disease (7) 7
aspirin - administration & dosage (7) 7
association (7) 7
blood platelets (7) 7
coronary artery disease (7) 7
electrocardiography (7) 7
hemorrhage (7) 7
hospitalization (7) 7
intervention (7) 7
medical colleges (7) 7
medicine (7) 7
primary percutaneous coronary intervention (7) 7
prognosis (7) 7
pyridines - therapeutic use (7) 7
research (7) 7
risk assessment (7) 7
usage (7) 7
acute coronary syndrome - mortality (6) 6
adenosine - analogs & derivatives (6) 6
angina pectoris (6) 6
birds (6) 6
bleeding (6) 6
cardiac and cardiovascular systems (6) 6
cardiology and cardiovascular medicine (6) 6
clinical trials (6) 6
cohort studies (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
Trinity College (John W Graham) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Art - Library use only (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Robarts - Reference (1) 1
Trinity College (John W Graham) - Wycliffe Storage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 8, pp. 823 - 833
BACKGROUND—Dual antiplatelet therapy in older versus younger patients with acute coronary syndromes is understudied. Low-dose prasugrel (5 mg/d) is recommended... 
CARDIAC & CARDIOVASCULAR SYSTEMS | drug therapy | ANTAGONIST | receptors | ST-SEGMENT-ELEVATION | MYOCARDIAL-INFARCTION | STRATEGY | myocardial infarction | fibrinolytic agents | HEALTH-CARE PROFESSIONALS | SCIENTIFIC STATEMENT | HEART-ASSOCIATION COUNCIL | CLINICAL CARDIOLOGY | COLLABORATION | PERIPHERAL VASCULAR DISEASE | aging | THROMBOLYTIC THERAPY | purinergic P2Y12 | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Age Factors | Thiophenes - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Hemorrhage - prevention & control | Dose-Response Relationship, Drug | Purinergic P2Y Receptor Antagonists - adverse effects | Aspirin - adverse effects | Ticlopidine - adverse effects | Aged, 80 and over | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Hemorrhage - epidemiology | Risk Factors | Treatment Outcome | Piperazines - therapeutic use | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Aged | Disease Management | Longitudinal Studies | Percutaneous Coronary Intervention | Aggregation | Usage | Blood platelets | Patient outcomes | Clopidogrel | Dosage and administration | Drug therapy | Health aspects | Heart attack
Journal Article
Circulation, ISSN 0009-7322, 06/2011, Volume 123, Issue 23, pp. 2681 - 2689
Journal Article
Circulation, 07/2019, Volume 140, Issue 2, p. 103
Previous trials of PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitors demonstrated reductions in major adverse cardiovascular events, but not... 
Journal Article
SA Heart, ISSN 2071-4602, 09/2018, Volume 15, Issue 3, pp. 214 - 216
The South African Heart Association (SA Heart®) was established in 1999. Prior to 1999, 2 professional societies represented the interests of cardiologists and... 
South African Heart Association | history of the South African Cardiac Society | history of the South African Society of Cardiac Practitioners
Journal Article
SA Heart, ISSN 2071-4602, 03/2017, Volume 12, Issue 1
Journal Article
by White, Harvey D and Held, Claes and Stewart, Ralph and Tarka, Elizabeth and Brown, Rebekkah and Davies, Richard Y and Budaj, Anzej and Harrington, Robert A and Steg, P. Gabriel and Ardissino, Diego and Armstrong, Paul W and Avezum, Alvaro and Aylward, Philip E and Bryce, Alfonso and Chen, Hong and Chen, Ming-Fong and Corbalan, Ramon and Dalby, Anthony J and Danchin, Nicolas and de Winter, Robbert J and Denchev, Stefan and Diaz, Rafael and Elisaf, Moses and Flather, Marcus D and Goudev, Assen R and Granger, Christopher B and Grinfeld, Liliana and Hochman, Judith S and Husted, Steen and Kim, Hyo-Soo and Koenig, Wolfgang and Linhart, Ales and Lonn, Eva and López-Sendón, José and Manolis, Athanasios J and Mohler, Emile R and Nicolau, José C and Pais, Prem and Parkhomenko, Alexander and Pedersen, Terje R and Pella, Daniel and Ramos-Corrales, Marco A and Ruda, Mikhail and Sereg, Mátyás and Siddique, Saulat and Sinnaeve, Peter and Smith, Peter and Sritara, Piyamitr and Swart, Henk P and Sy, Rody G and Teramoto, Tamio and Tse, Hung-Fat and Watson, David and Weaver, W. Douglas and Weiss, Robert and Viigimaa, Margus and Vinereanu, gos and Zhu, Junren and Cannon, Christopher P and Wallentin, Lars and Steg, Ph Gabriel and Bucan, Olga and Elfström, Charlotta and Hegg, Lisa and Jarosz, Marie and Krug-Gourley, Sue and Rudman, Jerry and Collins, Rory and Anderson, Jeffrey and DeMets, David and Ganz, Peter and Sandercock, Peter and Weber, Michael and Fisher, Marian and Buhr, Kevin and Diegel, Scott and Schultz, Melissa and Mahaffey, Kenneth W and Alexander, John H and Al-Khatib, Sana and Baron, Tomasz and Bergström, Olle and Bushnell, Cheryl and Christersson, Christina and Eggers, Kai and Fredlund, Bengt-Olov and Hagström, Emil and Hijazi, Ziad and Örndahl, Lovisa Holm and James, Stefan K and Jernberg, Tomas and Johnston, Nina and Lopez, Renato D and Mehta, Rajena H and Newby, Kristin L and Nordmark, Örjan and Oldgren, Jonas and Roe, Matthew T and Saldéen, Katarina and Stenborg, Anna and ... and The STABILITY Investigators and STABILITY Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Cardiovascular Journal of Africa, ISSN 1995-1892, 11/2016, Volume 27, Issue 6, pp. 392 - 398
Broadly speaking, management targets are avoidance of any exposure to smoking, a diet low in saturated fat, activity for at least 150 minutes each week, a body... 
DOUBLE-BLIND | CARDIAC & CARDIOVASCULAR SYSTEMS | HYPERKALEMIA | Humans | Risk Factors | Cardiovascular Diseases - therapy | Cardiovascular Diseases - epidemiology | Preventive Health Services | Biomedical Research | Cardiology | Cardiovascular Diseases - diagnosis | Congress Report
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 15, pp. 1404 - 1413
Patients with atherosclerotic vascular disease were randomly assigned to receive the thrombin antagonist vorapaxar or placebo. Vorapaxar reduced the rate of... 
TRIAL | STROKE | MEDICINE, GENERAL & INTERNAL | PROTEASE-ACTIVATED RECEPTORS | CLOPIDOGREL | ANTITHROMBOTIC AGENTS | SAFETY | TOLERABILITY | DOUBLE-BLIND | ACUTE CORONARY SYNDROMES | ASPIRIN | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Computer Science | Medical Imaging
Journal Article